STOCK TITAN

Becton Dickinson (NYSE: BDX) CFO DelOrefice reports equity award vesting

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Becton Dickinson & Co. executive vice president and chief financial officer Christopher DelOrefice reported routine equity award activity. On 11/26/2025, he acquired 6,006 shares of common stock at $0 per share, representing shares received upon vesting of performance-based equity awards. On the same date, 4,245 shares were disposed of at $0 per share, reflecting shares withheld to cover tax obligations tied to this vesting and previously granted restricted stock units. After these transactions, DelOrefice directly beneficially owned 22,982 shares of Becton Dickinson common stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
DelOrefice Christopher

(Last) (First) (Middle)
C/O BECTON, DICKINSON AND COMPANY
1 BECTON DRIVE

(Street)
FRANKLIN LAKES NJ 07417

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
BECTON DICKINSON & CO [ BDX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP & Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
11/26/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/26/2025 A 6,006(1) A $0 27,227 D
Common Stock 11/26/2025 F 4,245(2) D $0 22,982 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares received upon vesting of performance-based equity awards.
2. Represents shares withheld for payment of withholding taxes in connection with (A) the vesting of the performance units referred to in footnote (1) and (B) the vesting of restricted stock units previously reported on Table I.
Remarks:
Donna Kalazdy, by power of attorney from Christopher DelOrefice 12/01/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Becton Dickinson (BDX) report for its CFO?

Becton Dickinson reported that EVP & Chief Financial Officer Christopher DelOrefice acquired 6,006 shares of common stock on 11/26/2025 upon vesting of performance-based equity awards and had shares withheld for taxes.

How many Becton Dickinson (BDX) shares does the CFO own after this Form 4?

Following the reported transactions, Christopher DelOrefice beneficially owned 22,982 shares of Becton Dickinson common stock in direct ownership.

Why were some Becton Dickinson (BDX) shares disposed of in this filing?

The filing states that 4,245 shares were disposed of to cover withholding taxes related to the vesting of performance units and previously reported restricted stock units.

What is the nature of the shares acquired by the Becton Dickinson (BDX) CFO?

The 6,006 shares acquired were received upon the vesting of performance-based equity awards, a form of stock compensation tied to performance criteria.

Were these Becton Dickinson (BDX) insider transactions part of the CFO’s compensation?

Yes. The filing explains that the shares acquired reflect performance-based equity awards and that some shares were withheld to pay taxes due upon vesting of these awards and earlier restricted stock units.

Becton Dickinson & Co

NYSE:BDX

BDX Rankings

BDX Latest News

BDX Latest SEC Filings

BDX Stock Data

58.83B
283.77M
0.57%
92.26%
1.59%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
FRANKLIN LAKES